Chu Nantes;Universite de Nantes;Institut National de la Sante et de la Recherche Medicale (INSERM)
发明人:
Dominique Heymann,Aude Segaliny,Régis Brion
申请号：
US15536962
公开号：
US20170342148A1
申请日:
2015.12.21
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present disclosure relates to novel anti IL-34 antibodies or antigen-binding fragments thereof specifically binding cytokine IL-34 with high affinity, the method of obtaining of these antibodies and their therapeutic use.
